Ennaid Therapeutics | Ennaid Therapeutics Wins!
19038
post-template-default,single,single-post,postid-19038,single-format-standard,ajax_fade,page_not_loaded,,qode-theme-ver-7.7,wpb-js-composer js-comp-ver-5.2.1,vc_responsive

Ennaid Therapeutics Wins!

24 Jun Ennaid Therapeutics Wins!

Congratulations to Ennaid Therapeutics, the 2013 winner of Run It By The Pros business plan competition on June 5th!

Hosted by the MIT Enterprise Forum, Run It By The Pros is an event in which the Atlanta entrepreneur community takes a behind-the-scenes look at the advisor-investor-entrepreneur relationship. This year’s panel of experts included, Adam Ghetti of Ionic Security, Steve Ennaid-WinsHindman, a serial CEO, John Mandile of Sigma Prime and Clint Crosby of Baker Donelson. On June 5, the experts and the audience examined and discussed the real-life business plans of Ennaid Therapeutics, SafelyStay and Shark as presented by their entrepreneurial founders about their ventures. Each founder received actionable feedback and mentoring.

The start-up biopharmaceutical company’s first offering is using its innovative technology to rapidly develop a drug that significantly inhibits all four strains of dengue virus, a mosquito-borne virus that is endemic to tropical and sub tropical regions of the world and causes dengue fever, dengue hemorrhagic fever and dengue shock syndrome. Nearly 400 million people in 125 countries contract the virus annually. “We are excited to have won this prestigious event and be among successful past winners, such as SoloHealth, as we continue to focus on achieving key corporate and development milestones,” said Darnisha Harrison, founder, president and chief executive officer of Ennaid Therapeutics.

MIT Enterprise Forum, Run It By The Pros

No Comments

Sorry, the comment form is closed at this time.